Research programme: infectious disease vaccines - VaxInnate

Drug Profile

Research programme: infectious disease vaccines - VaxInnate

Alternative Names: flagellin.AvHA; flagellin.AvM2e; Hemagglutinin (HA)-based pandemic influenza vaccines - VaxInnate; Hemagglutinin (HA)-based seasonal influenza vaccines - VaxInnate; Human papillomavirus (HPV) vaccine - VaxInnate; Respiratory syncytial virus (RSV) infections - VaxInnate; Swine flu vaccine - VaxInnate

Latest Information Update: 11 Sep 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator VaxInnate
  • Class Bacterial vaccines; Influenza A vaccines; Papillomavirus vaccines; Recombinant fusion proteins; Viral vaccines
  • Mechanism of Action Immunostimulants; Toll-like receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Clostridium-difficile-infections; Human papillomavirus infections; Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Respiratory syncytial virus infections

Most Recent Events

  • 08 Oct 2015 Preclinical trials in Clostridium difficile infections in USA (Parenteral)
  • 24 Feb 2011 VaxInnate receives a contract from the Biomedical Advanced Research and Development Authority (BARDA) for development of Recombinant influenza vaccines in USA
  • 13 Jan 2010 Swine flu vaccine licensed to Biological E in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top